基因表达特征分析确定了状细胞疾病中血管封闭性发作的潜在生物标志物
Varsha Bhat1, Justin J Yoo2, Srija Ponna2
1Center for Integrative Genomics, School of Biological Sciences, Georgia Institute of Technology, Atlanta, Georgia, USA.
JCI insight
|March 9, 2026
概括
在状细胞疾病 (SCD) 中,血管封闭性发作 (VOE) 涉及复杂的细胞相互作用. 研究人员在VOE期间确定了白细胞和红色素细胞中的关键基因表达变化和潜在生物标志物,从而提供了对疾病机制的见解.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 基因组学就是基因组学.
背景情况:
- 血管封闭性发作 (VOE) 是状细胞疾病 (SCD) 的特征,涉及状红细胞与其他血液细胞之间的复杂相互作用.
- 了解VOE背后的分子机制对于开发有效的治疗方法至关重要.
研究的目的:
- 在SCD患者中分析周围血液转录组在稳定状态期间的变化与VOE.
- 为了确定VOEs的潜在基因表达生物标志物.
- 为了比较慢性疼痛和没有慢性疼痛的SCD患者在VOE期间的途径丰富.
主要方法:
- 追踪了174名患有SCD的人群.
- 在稳定状态和VOE期间采集了外周血液样本.
- 在CD45+白细胞和CD71+红色素细胞上进行RNA-Seq分析.
主要成果:
- 白细胞在VOE期间显示了补充激活,凝血和IL-6/JAK/STAT3信号传递中的丰富途径.
- 红状腺细胞在VOE期间表现出细胞循环途径的丰富,包括mTORC1信号和G2M检查点.
- 在VOEs期间,FAM20A,IL1B,MS4A4A和SERPINB2的表达升高. 患有慢性疼痛的患者在VOE期间显示出44%的途径丰富.
结论:
- 在SCD中,稳定状态和VOE之间存在显著的转录组差异,白细胞和红细胞中具有明显的途径丰富.
- 特定的基因 (FAM20A,IL1B,MS4A4A,SERPINB2) 显示出作为VOE生物标志物的潜力.
- 在SCD患者中,慢性疼痛与VOE期间途径激活的增加有关.
相关概念视频
02:24Ribosome Profiling
4.3K
Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
4.3K
01:29Pharmacogenomics: Identification of New Drug Targets
57
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
57